MeSH D007855 - lead poisoning
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D000075322:Heavy metal poisoning
0 Companies
0 Drugs
Success rate
D007855:
Lead poisoning
D020263:Nervous system lead poisoning
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Allergan | Penicillamine | Penicillamine | 2019-06-24 | |||
| Apotex | Penicillamine | Penicillamine | 2020-04-28 | |||
| Bausch Health Companies | Penicillamine | Cuprimine | 1982-01-01 | |||
| Breckenridge Pharmaceutical | Penicillamine | Penicillamine | 2021-08-23 | |||
| Cipla | Penicillamine | Penicillamine | 2021-08-19 | |||
| Dr Reddys Laboratories | Penicillamine | Penicillamine | 2020-08-04 | |||
| Endo | Penicillamine | Penicillamine | 2019-12-23 | |||
| Granules Pharmaceuticals | Penicillamine | Penicillamine | 2020-12-02 | |||
| Lupin Research | Penicillamine | Penicillamine | 2020-11-30 |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
100%1/1
Phase 3
100%3/3
Approved: 2Overall Success rate: 0%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use